Abbott Laboratories SG&A Expenses 2010-2024 | ABT

Abbott Laboratories sg&a expenses for the twelve months ending September 30, 2024 were $11.514B, a 2.82% increase year-over-year.

  • Abbott Laboratories annual sg&a expenses for 2023 were $10.949B, a 2.66% decline from 2022.
  • Abbott Laboratories annual sg&a expenses for 2022 were $11.248B, a 0.67% decline from 2021.
  • Abbott Laboratories annual sg&a expenses for 2021 were $11.324B, a 16.79% increase from 2020.

Abbott Laboratories SG&A Expenses 2010-2024 | ABT

  • Abbott Laboratories annual sg&a expenses for 2023 were $10.949B, a 2.66% decline from 2022.
  • Abbott Laboratories annual sg&a expenses for 2022 were $11.248B, a 0.67% decline from 2021.
  • Abbott Laboratories annual sg&a expenses for 2021 were $11.324B, a 16.79% increase from 2020.